Medications for Granulomatosis With Polyangiitis
3 results
Rituxan (rituximab)
(rituximab)Genentech, Inc.
Usage: RITUXAN is indicated for treating various conditions, including relapsed or refractory Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and pemphigus vulgaris in adults. It is also approved for pediatric patients with advanced stage CD20-positive lymphomas.
Ruxience (rituximab-pvvr)
(rituximab-pvvr)Pfizer Laboratories Div Pfizer Inc
Usage: RUXIENCE is indicated for adult patients with relapsed or refractory Non-Hodgkin's lymphoma (NHL), untreated follicular NHL, chronic lymphocytic leukemia (CLL), moderately-to-severely active rheumatoid arthritis inadequately responding to TNF antagonists, and for treating Granulomatosis with Polyangiitis and Microscopic Polyangiitis in combination with glucocorticoids.
Tavneos (avacopan)
(avacopan)ChemoCentryx, Inc.
Usage: TAVNEOS is indicated as an adjunctive treatment for adult patients with severe active ANCA-associated vasculitis (specifically granulomatosis with polyangiitis and microscopic polyangiitis) in combination with standard therapy, including glucocorticoids, but does not replace glucocorticoid use.